# Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SUVN-I6107 In Healthy Participants

> **NCT06705088** · PHASE1 · COMPLETED · sponsor: **Suven Life Sciences Limited** · enrollment: 64 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** SUVN-I6107
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06705088
- **Lead sponsor:** Suven Life Sciences Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-07
- **Primary completion:** 2025-12-02
- **Final completion:** 2025-12-02
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06705088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06705088, "Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SUVN-I6107 In Healthy Participants". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06705088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*